World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

METHOD DEVELOPMENT AND VALIDATION OF ANTICANCER DRUGS (NILOTINIB AND GEMCITABINE) BY RP-HPLC METHOD

*Dara.Varun Kumar and Kumaraswamy.Gandla

ABSTRACT

A simple, fast, accurate and precise UV-spectroscopic method and RP-HPLC method were developed and validated for the estimation of Nilotinib/Gemcitabine per ICH guidelines. Acetonitrile and water (50:50) was used as the solvent. The ? max of Nilotinib/Gemcitabine was found to be 242 nm and it was proved linear in the concentration range of Nilotinib 0.5-3?g/ml and for Gemcitabine 1-6?g/ml with a correlation coefficient value of 0.999. Accuracy studies of UV-spectroscopy method was performed at three different levels, i.e., 50%, 100%, and 150% and recovery was found to be in the range of 99.6 to 100.8% for Nilotinib and the range of 98.3 to 101.2% for Gemcitabine respectively. The Limit of Detection (LOD) and Limit of Quantification (LOQ) were found to be 0.217 and 0.658 ?g/ml for Nilotinib and 0.103 and 0.312 f or Gemcitabine RP-HPLC method was developed by using Acetonitrile: water, 0.1% ortho phosphoric acid (50:50). The method was developed in Eclipse C18 column (100 mm × 4.6 mm, 3.5?m particle size). In RP-HPLC method was found to be linear in the range of Nilotinib/Gemcitabine is 0.25-1.5?g/ml with a correlation coefficient value of 0.999. The accuracy studies of RP-HPL C method was performed at three different levels, i.e., 50%, 100%, and 150% and recovery was found to be in the range of 98.24 t o 100.3% for Nilotinib and the range of 98.18 to 99.98% and for Gemcitabine respectively. The limit of detection (LOD) and Li mit of Quantification (LOQ) were found to be 0.0421 and 0.1276 ?g/ml for Nilotinib and 0.047.and 0.1424 ?g/ml for Capecit abine for RP-HPLC method. The % RSD is <2% which indicates the accuracy and precision of the method. The abo ve method was a rapid tool for routine analysis of Nilotinib/Gemcitabine in the bulk and in the pharmaceutical dosage form.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR